Cabot (CBT) Q3 EPS Beats by 4%
(NYSE:CBT), a leading specialty chemicals maker known for its reinforcement and performance materials used in automotive and industrial sectors, reported its earnings for the quarter ended June 30, 2025, on August 4, 2025. The headline news from the release was a beat on adjusted earnings per share, with $1.90 versus the consensus estimate of $1.82. However, GAAP revenue missed at $923 million compared to an estimated $954.95 million and was down from $1,016 million (GAAP) in Q3 FY2024. The quarter reflected weaker sales volumes across core segments, yet margins held up thanks to cost discipline and ongoing savings programs. Overall, Cabot’s ability to deliver earnings above targets in a softer market environment came mainly from meticulous operational controls, even as demand—especially in tire and automotive applications—remained subdued.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q2 2025 earnings report.
(NYSE:CBT) is a global specialty chemicals company that develops and manufactures products such as reinforcing carbons and engineered composites, which are essential in making tires more durable and efficient, as well as advanced materials used in coatings, batteries, and electronics. Its two key business units are Reinforcement Materials and Performance Chemicals.
Source Fool.com
Cabot Corp. Stock
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Cabot Corp..
With a target price of 108 € there is a hugely positive potential of 60.0% for Cabot Corp. compared to the current price of 67.5 €.
